Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease.
OBJECTIVE
To investigate the possibility that response to cholinesterase inhibitor therapy could be predicted by easily measurable variables that are known to change as a result of treatment (such as the Mini Mental State Examination), measures of function (such as the instrumental activities of daily living and the social behaviour subscales of the Nurse's Observation Scale for Geriatric Patients), and measures of attention (such as the Digit Symbol Substitution Test; DSST), or that might influence response through structural (for example, age, cerebrovascular disease, medial temporal lobe (MTL) atrophy, hypertension) or chemical (for example, smoking) mechanisms.


METHODS
This was a cohort study of 160 consecutive outpatients with probable Alzheimer's disease who commenced cholinesterase inhibitor treatment over a 3 year period in a semi-rural area of Scotland.


RESULTS
The overall response rate was 42.1%. Stratification of response between good and poor responders was possible using baseline DSST and a measure of MTL thickness using CT. Among the patients, 60.4% of those above the cut off point for both DSST and MTL thickness (29/48 subjects) were classified as good responders, compared with 6.3% of subjects below the cut off point for both (1/16 subjects). Subjects above the cut off point for both measures were more likely to be classified as good responders than subjects with only one or no values above the respective cut off points (chi(2) = 10.61, df = 1, p = 0.001)


CONCLUSIONS
The DSST and a measure of MTL thickness derived from CT scanning may be useful in improving the prediction of response to cholinesterase inhibitors in subjects with AD. Subjects with low DSST scores and more severe MTL atrophy are unlikely to respond to treatment. These preliminary data justify a prospective trial of the usefulness of our suggested predictive measures.
Connelly
P J
PJ
Department of Psychiatry, University of Dundee, Murray Royal Hospital, Muirhall Road, Perth, PH2 7BH, UK. pjc@dementiaresearch.freeserve.co.uk
Prentice
N P
NP
Fowler
K G
KG
D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D015577:Geriatric Assessment; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D009730:Nursing Assessment; D011237:Predictive Value of Tests; D011379:Prognosis; D012307:Risk Factors; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors
Ann Neurol. 1980 May;7(5):486-8
7396427
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12260-4
8618881
Arch Neurol. 1988 Jun;45(6):637-41
3259421
J Am Geriatr Soc. 1991 Apr;39(4):339-47
2010583
Arch Neurol. 1992 Jun;49(6):626-32
1596198
Neuropsychobiology. 1992;25(1):24-8
1603291
Lancet. 1992 Nov 14;340(8829):1179-83
1359259
Dementia. 1993 Jan-Feb;4(1):54-8
8358507
Psychopharmacology (Berl). 1993;110(4):395-401
7870908
Int J Geriatr Psychiatry. 2000 Jan;15(1):50-3
10637404
Eur J Neurol. 2000 Mar;7(2):159-69
10809936
Methods Find Exp Clin Pharmacol. 2000 Mar;22(2):115-22
10849895
Neurology. 2000 Jun 27;54(12):2261-8
10881250
Neurology. 2000 Jun 27;54(12):2269-76
10881251
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):431-6
8774411
Neuroreport. 1997 May 27;8(8):1845-9
9223063
Int J Geriatr Psychiatry. 1998 Oct;13(10):661-6
9818300
BMJ. 1999 Mar 6;318(7184):633-8
10066203
Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):237-44
10325453
Int Psychogeriatr. 2000 Jun;12(2):231-47
10937543
Int J Geriatr Psychiatry. 2000 Aug;15(8):713-20
10960883
Dement Geriatr Cogn Disord. 2000 Sep;11 Suppl 1:19-27
10971048
Dement Geriatr Cogn Disord. 2001 Jan-Feb;12(1):22-32
11125238
Dement Geriatr Cogn Disord. 2001 Mar-Apr;12(2):69-77
11173877
Arch Neurol. 2001 Mar;58(3):417-22
11255445
Neurology. 2001 Aug 14;57(3):489-95
11502918
Int J Geriatr Psychiatry. 2001 Sep;16(9):837-45
11571761
Age Ageing. 2003 Mar;32(2):200-4
12615565
Int J Geriatr Psychiatry. 2003 Apr;18(4):308-12
12673606
Dement Geriatr Cogn Disord. 2003;16(3):119-25
12826736
J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):292-4
14742608
Br J Psychiatry. 1969 Mar;115(520):267-71
5794120
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
Psychopharmacology (Berl). 1995 Mar;118(1):82-92
7597126
Arch Neurol. 1995 Jul;52(7):659-64
7619020
Neuroreport. 1995 Jun 19;6(9):1297-300
7669991
Neurology. 1984 Jul;34(7):939-44
6610841